Clinical Trial Update: Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ethanol lock therapy for treatment and secondary prophylaxis of central line-associated bloodstream infection has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Line-associated Bloodstream Infection

Drugs mentioned

• Ethanol Lock Therapy (ethanol lock therapy)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Central Line-Associated Bloodstream Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-11-13